MDT

96.72

-0.11%↓

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

MDT

96.72

-0.11%↓

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

MDT

96.72

-0.11%↓

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

MDT

96.72

-0.11%↓

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

MDT

96.72

-0.11%↓

139.6

-0.01%↓

VEEV

222.15

-0.07%↓

HQY

85.02

0%↓

NEOG

9.23

-0.11%↓

Inicio・Lista de Acciones・CorMedix Inc

CorMedix Inc

Cerrado

SectorSanidad

6.77 -0.15

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

6.77

Máximo

6.77

Métricas clave
By Trading Economics
Ingresos	89M 109M
Ventas	65M 104M
P/B Media del Sector	3.235 90.831
Margen de beneficios	104.112
Empleados	64
EBITDA	37M 57M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+150.74% upside

Dividendos
By Dow Jones
Próximas Ganancias	24 mar 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-305M 563M
Apertura anterior	6.92
Cierre anterior	6.77

Noticias sobre sentimiento de mercado

By Acuity

41%

59%

145 / 361 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

9.2 / N/A Soporte y Resistencia

CorMedix Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

19 ene 2026, 16:17 UTC

Adquisiciones, fusiones, absorciones

Zurich Insurance Makes $10 Billion Bid for U.K. Specialist Insurer Beazley -- Update

19 ene 2026, 23:50 UTC

Charlas de Mercado

Nikkei May Decline Amid Uncertainty Over U.S.-Europe Relations -- Market Talk

19 ene 2026, 23:42 UTC

Charlas de Mercado

Gold Edges Lower on Likely Technical Correction -- Market Talk

19 ene 2026, 22:29 UTC

Charlas de Mercado

China Infant Formula Market May Hold Up Despite Steep Drop in Births -- Market Talk

19 ene 2026, 22:29 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

19 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

19 ene 2026, 21:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

19 ene 2026, 21:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

19 ene 2026, 17:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

19 ene 2026, 17:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

19 ene 2026, 17:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

19 ene 2026, 17:09 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

19 ene 2026, 17:09 UTC

Charlas de Mercado

Copper Rises in Spite of Softer Dollar, Trade Concerns -- Market Talk

19 ene 2026, 16:18 UTC

Charlas de Mercado

New Zealand Dollar Could Recover Against Swedish Krona -- Market Talk

19 ene 2026, 16:12 UTC

Charlas de Mercado

Norwegian Krone's Recent Gains Are Unlikely to Last -- Market Talk

19 ene 2026, 16:06 UTC

Adquisiciones, fusiones, absorciones

LVMH: Deal Completion Subject to Customary Closing Conditions and Expected to Close in Around Two Months

19 ene 2026, 16:04 UTC

Adquisiciones, fusiones, absorciones

LVMH: Both Parties Aim to Set Up Strategic Cooperation in the Retail Sector

19 ene 2026, 16:03 UTC

Adquisiciones, fusiones, absorciones

LVMH, CTG Duty-Free Also Entered Into a MoU

19 ene 2026, 16:02 UTC

Adquisiciones, fusiones, absorciones

LVMH: Subscription to Be Made Upon Completion of Transaction

19 ene 2026, 16:00 UTC

Adquisiciones, fusiones, absorciones

LVMH: Capital Increase by Subscribing to Newly Issued H-shares Listed in Hong Kong

19 ene 2026, 16:00 UTC

Charlas de Mercado

Term Premium on U.S. Treasurys Looks Too Low, Says Pictet AM -- Market Talk

19 ene 2026, 15:58 UTC

Adquisiciones, fusiones, absorciones

LVMH and the Miller Family Will Participate in a Capital Increase of CTG DutyFree

19 ene 2026, 15:57 UTC

Adquisiciones, fusiones, absorciones

LVMH: DFS Will Continue to Operate Its Other Luxury Travel Retail Operations Worldwide

19 ene 2026, 15:57 UTC

Adquisiciones, fusiones, absorciones

LVMH: Proceeds of Transaction Will Be Paid in Cash

19 ene 2026, 15:56 UTC

Adquisiciones, fusiones, absorciones

LVMH: CTG Duty-Free Will Run the Acquisition Through Its Subsidiary China Duty Free International Limited

19 ene 2026, 15:53 UTC

Adquisiciones, fusiones, absorciones

LVMH: Intangible Assets Include a Series of DFS Brands and IP for Exclusive Use in Greater China

19 ene 2026, 15:52 UTC

Adquisiciones, fusiones, absorciones

LVMH: CTG Duty-Free to Acquire the DFS Retail Stores in Hong Kong and Macau and Intangible Assets

19 ene 2026, 15:51 UTC

Adquisiciones, fusiones, absorciones

LVMH: DFS, CTG Duty-Free Reach Definitive Pact for CTG Duty-Free to Buy DFS' Travel Retail Unit in Hong Kong and Macau and Intangible Assets in Greater China

19 ene 2026, 15:39 UTC

Charlas de Mercado

Canadian Dollar's Underperformance Looks Overstretched -- Market Talk

19 ene 2026, 15:37 UTC

Charlas de Mercado

Bank of Canada Could Consider Cutting Rates if Underlying Inflation Slows Further -- Market Talk

Comparación entre iguales

Cambio de precio

CorMedix Inc previsión

Precio Objetivo

By TipRanks

150.74% repunte

Estimación a 12 Meses

Media 17 USD 150.74%

Máximo 22 USD

Mínimo 14 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CorMedix Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

Comprar

Mantener

Vender

De acuerdo con 6 analistas que ofrecen calificaciones bursátiles a para CorMedix Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

9.2 / N/ASoporte y Resistencia

Recent bullish events outweigh bearish events.

All events are bullish.

Sentimiento

By Acuity

145 / 361 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.